We can help you
Your clinical trials (in terms of costs and time)
go / no-go
in pay for outcome scenarios
- December 13th, 2021
Developing an imaging-based companion diagnostic tool with Radiomics
The second part in the series of articles about imaging-based companion diagnostics will focus on their development and is available to read here.
- December 1st, 2021
Radiomics joins the FNIH Biomarkers Consortium
Radiomics is proud to join the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC).
- November 25th, 2021
Radiomics announces the strategic support of OncoDNA in its prospective clinical trial SALMON
The two Belgian companies will work towards a better understanding of non-small cell lung cancer biology and characterization of the tumors using of AI technology